Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | FBP1 | P09467 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
| ▸ | GABRD | O14764 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7941828 | 0.89 | TP53 (0.43) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL10487749 | 0.83 | ALDH1A1 (0.39) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL4876434 | 0.81 | HTT (0.38) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL8977186 | 0.81 | GRIN2D (0.40) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL10606796 | 0.81 | TP53 (0.38) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL1538857 | 0.81 | ALDH1A1 (0.51) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL10951675 | 0.80 | DTYMK (0.39) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL3127548 | 0.79 | TP53 (0.37) | TP53HTTFBP1ALDH1A1TSHR | |
| SCHEMBL17164149 | 0.79 | TSHR (0.51) | TP53HTTALDH1A1TSHRCYP3A4 | |
| SCHEMBL28910119 | 0.78 | TSHR (0.46) | TP53HTTFBP1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1937407-B1 | SOLUTIONS OF ANHYDROUS LANTHANIDE SALTS AND ITS PREPARATION | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2015-04-22 | — | — | EP | disclosed |
| US-8524917-B2 | 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity | ALLERGAN, INC. (US) | 2013-09-03 | — | — | US | disclosed |
| US-8470982-B2 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET (DE) | 2013-06-25 | — | — | US | disclosed |
| US-20090326235-A1 | Solutions of anhydrous lanthanide salts and its preparation | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20080171772-A1 | e.g. Methyl 1-Benzyl-6-methoxy-1H-indole-2-carboxylate; glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, wound healing, platelet aggregation and thrombosis | ALLERGAN, INC. | 2008-07-17 | — | — | US | disclosed |
| EP-1937407-A1 | SOLUTIONS OF ANHYDROUS LANTHANIDE SALTS AND ITS PREPARATION | Ludwig-Maximilians-Universität München (DE) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007026014-A1 | SOLUTIONS OF ANHYDROUS LANTHANIDE SALTS AND ITS PREPARATION | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2007-03-08 | — | — | WO | disclosed |
| EP-1759765-A1 | Solutions of anhydrous lanthanide salts and its preparation | Ludwig-Maximilians-Universität München (DE) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171772-A1 | e.g. Methyl 1-Benzyl-6-methoxy-1H-indole-2-carboxylate; glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, wound healing, platelet aggregation and thrombosis | PTGIR, S1PR1, TBXA2R | TP53 4095/4885HTT 4393/4885FBP1 3169/4885 |
| US-20090326235-A1 | Solutions of anhydrous lanthanide salts and its preparation | SLC39A3, AQP3, IKZF3 | TP53 1969/4885HTT 3355/4885FBP1 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.